Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
Public ClinicalTrials.gov record NCT00747539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the impact of standard hepatitis C virus treatment on brain deficits in people who are infected with both HIV and the hepatitis C virus.
Study identification
- NCT ID
- NCT00747539
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2008
- Primary completion
- May 31, 2015
- Completion
- May 31, 2015
- Last update posted
- May 12, 2016
2008 – 2015
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Infectious Diseases, Antelope Valley | Lancaster | California | 93534 | — |
| University of California, Los Angeles, School of Medicine | Los Angeles | California | 90024 | — |
| AIDS Healthcare Foundation | Los Angeles | California | 90028 | — |
| Veterans Administration Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated HIV trials
Other public records listing HIV. Sorted by last update posted; newest first. Not a recommendation.
- NCT07769580: Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior Not yet recruiting
- NCT07762066: Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual Men Recruiting
- NCT07757802: Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults Not yet recruiting
- NCT07502365: BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV Recruiting
- NCT06930508: Bringing Medicines for HIV Prevention to a Family Planning Clinic Recruiting
- NCT07728370: RISE: Reducing Cancer and HIV Stigma Through Empowerment Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00747539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2016 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00747539 live on ClinicalTrials.gov.